Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00368745
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2006-08-23
Brief Title:
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder GAD Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication Free From Benzodiazepine Use
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A0081092
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None